Pliant Therapeutics Announces Positive Topline Data from a Phase 2a Collagen PET Imaging Clinical Trial of Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis

FogPharma and ARTBIO Announce Collaboration to Co-Develp Multiple Helicon™-Enabled Alpha-Particle Radioligand Therapies for the Treatment of Cancer

CARGO Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2024

Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Development and Commercialization of Losmapimod in Facioscapulohumeral Muscular Dystrophy